[go: up one dir, main page]

AR036838A1 - Comprimido de varias capas de liberacion controlada, uso del mismo para la fabricacion de un medicamento util en el tratamiento de la fibromialgia y composicion farmaceutica que lo comprende. - Google Patents

Comprimido de varias capas de liberacion controlada, uso del mismo para la fabricacion de un medicamento util en el tratamiento de la fibromialgia y composicion farmaceutica que lo comprende.

Info

Publication number
AR036838A1
AR036838A1 ARP020103882A ARP020103882A AR036838A1 AR 036838 A1 AR036838 A1 AR 036838A1 AR P020103882 A ARP020103882 A AR P020103882A AR P020103882 A ARP020103882 A AR P020103882A AR 036838 A1 AR036838 A1 AR 036838A1
Authority
AR
Argentina
Prior art keywords
treatment
substances
manufacture
pharmaceutical composition
phibromialgia
Prior art date
Application number
ARP020103882A
Other languages
English (en)
Original Assignee
Smithkline Beecham Cork Ltd
Jagotec Ag
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Smithkline Beecham Cork Ltd, Jagotec Ag filed Critical Smithkline Beecham Cork Ltd
Publication of AR036838A1 publication Critical patent/AR036838A1/es

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/0012—Galenical forms characterised by the site of application
    • A61K9/0053—Mouth and digestive tract, i.e. intraoral and peroral administration
    • A61K9/0065—Forms with gastric retention, e.g. floating on gastric juice, adhering to gastric mucosa, expanding to prevent passage through the pylorus
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/20—Pills, tablets, discs, rods
    • A61K9/2072—Pills, tablets, discs, rods characterised by shape, structure or size; Tablets with holes, special break lines or identification marks; Partially coated tablets; Disintegrating flat shaped forms
    • A61K9/2086—Layered tablets, e.g. bilayer tablets; Tablets of the type inert core-active coat
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P21/00—Drugs for disorders of the muscular or neuromuscular system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P29/00—Non-central analgesic, antipyretic or antiinflammatory agents, e.g. antirheumatic agents; Non-steroidal antiinflammatory drugs [NSAID]
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/20—Pills, tablets, discs, rods
    • A61K9/2004—Excipients; Inactive ingredients
    • A61K9/2013—Organic compounds, e.g. phospholipids, fats
    • A61K9/2018—Sugars, or sugar alcohols, e.g. lactose, mannitol; Derivatives thereof, e.g. polysorbates
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/20—Pills, tablets, discs, rods
    • A61K9/2004—Excipients; Inactive ingredients
    • A61K9/2022—Organic macromolecular compounds
    • A61K9/205—Polysaccharides, e.g. alginate, gums; Cyclodextrin
    • A61K9/2054—Cellulose; Cellulose derivatives, e.g. hydroxypropyl methylcellulose

Landscapes

  • Health & Medical Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Chemical & Material Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Medicinal Chemistry (AREA)
  • Animal Behavior & Ethology (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Epidemiology (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • General Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Physiology (AREA)
  • Nutrition Science (AREA)
  • Rheumatology (AREA)
  • Pain & Pain Management (AREA)
  • Neurology (AREA)
  • Orthopedic Medicine & Surgery (AREA)
  • Physical Education & Sports Medicine (AREA)
  • Medicinal Preparation (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)

Abstract

Comprimido de varias capas, de liberación controlada, que comprende: (a) una capa activa que contiene: (i) ropinirol o una sal farmacéuticamente aceptable del mismo, como sustancia activa, (ii) sustancias poliméricas hidrófilas que se hinchan y/o gelifican y/o erosionan al contacto con líquidos acuosos; (iii) sustancias lipófilas y (iv) sustancias adyuvantes, en la que la relación ponderal de las sustancias poliméricas hidrófilas a las sustancias lipófilas contenidas en la citada capa activa está en el intervalo de 10:1 a 0,5:1; y (b) una o más capas barrera que contienen una o más sustancias poliméricas hidrófilas que se hinchan y/o gelifican y/o erosionan al contacto con líquidos acuosos, sustancias lipófilas y sustancias adyuvantes; siendo dicho comprimido de utilidad en un método para el tratamiento de la fibromialgia. Uso de dicho comprimido de varias capas, de liberación controlada, para la fabricación de un medicamento útil en el tratamiento de la fibromialgia. Una composición farmacéutica que comprende el comprimido de varias capas, de liberación controlada, descripto para su uso en el tratamiento de la fibromialgia.
ARP020103882A 2001-10-18 2002-10-16 Comprimido de varias capas de liberacion controlada, uso del mismo para la fabricacion de un medicamento util en el tratamiento de la fibromialgia y composicion farmaceutica que lo comprende. AR036838A1 (es)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
GBGB0125088.5A GB0125088D0 (en) 2001-10-18 2001-10-18 New use

Publications (1)

Publication Number Publication Date
AR036838A1 true AR036838A1 (es) 2004-10-06

Family

ID=9924131

Family Applications (1)

Application Number Title Priority Date Filing Date
ARP020103882A AR036838A1 (es) 2001-10-18 2002-10-16 Comprimido de varias capas de liberacion controlada, uso del mismo para la fabricacion de un medicamento util en el tratamiento de la fibromialgia y composicion farmaceutica que lo comprende.

Country Status (6)

Country Link
US (1) US20040247676A1 (es)
EP (1) EP1435921A1 (es)
JP (1) JP2005509630A (es)
AR (1) AR036838A1 (es)
GB (1) GB0125088D0 (es)
WO (1) WO2003035042A1 (es)

Families Citing this family (18)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
AR040682A1 (es) 2002-07-25 2005-04-13 Pharmacia Corp Forma de dosificacion una vez al dia de pramipexol
DE602004002405T3 (de) † 2003-05-14 2013-06-20 Aptalis Pharma Limited Kontrollierte medikamentfreigabe zusammensetzung mit in vivo mechanikstresswiderstand
GB0319874D0 (en) * 2003-08-22 2003-09-24 Glaxo Group Ltd Novel formulation
US20060024368A1 (en) * 2004-07-30 2006-02-02 Reza Fassihi Compressed composite delivery system for release-rate modulation of bioactives
NZ553645A (en) 2004-08-13 2010-09-30 Boehringer Ingelheim Int Extended release pellet formulation containing pramipexole or a pharmaceutically acceptable salt thereof, method for manufacturing the same and use thereof
DE102006043216A1 (de) * 2006-06-02 2007-12-06 Inoviscoat Gmbh Verbundmaterial und Verfahren zum Herstellen eines derartigen Verbundmaterials
TW200815045A (en) * 2006-06-29 2008-04-01 Jazz Pharmaceuticals Inc Pharmaceutical compositions of ropinirole and methods of use thereof
WO2009023761A2 (en) * 2007-08-14 2009-02-19 Dr. Reddy's Laboratories Ltd. Pharmaceutical compositions comprising ropinirole
SI22849A (sl) * 2008-08-01 2010-02-26 Krka, Tovarna Zdravil, D.D., Novo Mesto Ropinirolni pripravek
NZ592765A (en) * 2008-08-14 2013-06-28 Bioneer As Tablets with a coating which impedes the release of an active ingredient
US20110195117A1 (en) * 2008-09-01 2011-08-11 Lupin Limited Controlled release compositions of ropinirole
WO2010035245A2 (en) * 2008-09-29 2010-04-01 Wockhardt Research Centre Extended release dosage form of ropinirole
WO2010044108A2 (en) 2008-10-17 2010-04-22 Rubicon Research Private Limited Controlled release formulations of ropinirole
WO2011032416A1 (zh) * 2009-09-19 2011-03-24 浙江华海药业股份有限公司 含有多巴胺受体激动剂的药物组合物
BR112012022797A2 (pt) * 2010-03-09 2018-02-20 Alkermes Pharma Ireland Ltd composição farmacêutica resistente a álcool, e, método para tratar uma doença com uma formulação de agente ativo resistente a álcool
EP2830606A4 (en) * 2012-03-30 2015-08-12 Takeda Pharmaceuticals Usa Inc FORMULATIONS OF COLCHICINE; MANUFACTURING PROCESSES ; AND ASSOCIATED METHODS OF USE
ITFI20130189A1 (it) * 2013-08-05 2015-02-06 Valpharma Internat S P A Una composizione farmaceutica contenente ropinirolo hcl somministrabile per via orale e metodo di produzione.
MX2016009427A (es) * 2014-01-22 2016-12-08 Teva Pharmaceuticals Int Gmbh Formulaciones de pridopidina de liberacion modificada.

Family Cites Families (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
IT1318470B1 (it) * 2000-04-14 2003-08-25 Jagotec Ag Matrici polimeriche idrofile/lipofile, in grado di cedere sostanzefarmacologiamente attive a velocita' predeterminata.
AR030557A1 (es) * 2000-04-14 2003-08-27 Jagotec Ag Una tableta en multicapa de liberacion controlada y metodo de tratamiento
US6277875B1 (en) * 2000-07-17 2001-08-21 Andrew J. Holman Use of dopamine D2/D3 receptor agonists to treat fibromyalgia

Also Published As

Publication number Publication date
EP1435921A1 (en) 2004-07-14
US20040247676A1 (en) 2004-12-09
WO2003035042A1 (en) 2003-05-01
GB0125088D0 (en) 2001-12-12
JP2005509630A (ja) 2005-04-14

Similar Documents

Publication Publication Date Title
AR036838A1 (es) Comprimido de varias capas de liberacion controlada, uso del mismo para la fabricacion de un medicamento util en el tratamiento de la fibromialgia y composicion farmaceutica que lo comprende.
AR030557A1 (es) Una tableta en multicapa de liberacion controlada y metodo de tratamiento
ES2182397T3 (es) Comprimido para la liberacion instantanea y prolongada de una o mas substancias activas.
AU719170B2 (en) Pharmaceutical compressed tablet characterized by a high increase in volume by contact with biological fluids
CA2264250A1 (en) Tablet with controlled release of alfuzosin hydrochloride
ATE269709T1 (de) Tablette mit verzögerter freigabe enthaltend einen blutzuckersenkenden wirkstoff und einen antihyperglyzemischen wirkstoff
DE69729134D1 (de) Pharmazeutische Tablette geeignet zur Wirkstofffreisetzung in aufeinanderfolgenden und vorherbestimmbaren Zeiträumen
AR005281A1 (es) Composicion farceutica oral , procedimientos para su manufactura y uso de esa composicion farmaceutica para la preparacion de medicamentos. .
ES2031491T3 (es) Tableta para uso farmaceutico capaz de liberar sustancias activas en momentos sucesivos.
ES2106818T3 (es) Composicion multicapa que contiene antagonistas de histamina o secotina.
EP1275381A4 (en) SOLID COATED PREPARATIONS WITH TEMPERATURE RELEASE FOR ORAL ADMINISTRATION
AR018582A1 (es) Forma de dosificacion en tableta para administrar un antagonista de los receptores de los leucotrienos y su uso en la preparacion de medicamentos
JPH072649A (ja) 有効成分を徐放するための多層マトリックス系
KR900011486A (ko) 하이드로겔에 의해 작동되는 분배장치
ES2136157T3 (es) Producto granular o comprimido que contiene un sistema efervescente y una sustancia farmaceutica activa, asi como un procedimiento para su preparacion.
ATE454887T1 (de) Therapeutisches system für die kontrollierte freisetzung von wirkstoffen
CY1112738T1 (el) Μια συνδυασμενη συνθεση που περιεχει ιβουπροφαινη και παρακεταμολη
ATE232100T1 (de) Gegen magensaft geschützte omeprazol- mikrogranülen, herstellungsverfahren und pharmazeutische zubereitungen
ATE361060T1 (de) Ionenstärkenunabhängige pharmazeutische formulierung mit verzögerter freisetzung
ES2195573T3 (es) Preparado farmaceutico solido con estructura multifase para administracion oral de gatifloxacina o sus sales o hidratos farmaceuticamente utilizables y procedimiento para su preparacion.
DE60125750D1 (de) Pharmazeutische formulierung enthaltend trägerkügelchen mit aufgebrachter schicht aus valaciclovir
CA2387710A1 (en) Preparation containing active ingredients and/or auxiliary agents with a controlled release of these substances and the use and production of the same
AR024201A1 (es) Parche que contiene productos farmaceuticos, con tres capas funcionales
HUP0300970A2 (hu) Epinastint és pszeudoefedrint tartalmazó új gyógyszerkészítmények
CA2671092A1 (en) Divisible osmotic dosage forms and methods of use

Legal Events

Date Code Title Description
FA Abandonment or withdrawal